APO Research, Inc.
Talk to an analyst

APO RESEARCH · REPORT

Furazolidone

Compare research editions
View pricing & licenses

Selected research

Market Structure

Global Furazolidone Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032

Report ID 173993510319 December 2025196 pages

Choose your research edition.

Industry ResearchFurazolidone Industry Research Report 2026129 pages · $2,950 USDIndustry Growth & TrendsGlobal Furazolidone Industry Growth and Trends Forecast to 2032108 pages · $3,450 USDMarket StructureGlobal Furazolidone Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032196 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Furazolidone Market Outlook and Growth Opportunities 2026191 pages · $4,250 USDMarket Analysis & ForecastGlobal Furazolidone Market Analysis and Forecast 2026-2032199 pages · $4,950 USD

Market perspective

The global Furazolidone market is projected to grow from US$ million in 2026 to US$ million by 2032, implying a CAGR of % over 2026-2032.

The US & Canada market for Furazolidone is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Furazolidone is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Furazolidone is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The China market for Furazolidone is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Furazolidone include Becton, Dickinson and Company (BD), Daiichi Sankyo, Ferring, Geo-Med, GrÜNenthal Gmbh, Keyfarm, KPL Pharma, Marvi and Standpharm, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Furazolidone market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Furazolidone and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Furazolidone sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Furazolidone market size, projected growth trends, production technologies, key applications, and end-use industries.

Furazolidone Segment by Company

Becton, Dickinson and Company (BD)

Daiichi Sankyo

Ferring

Geo-Med

GrÜNenthal Gmbh

Keyfarm

KPL Pharma

Marvi

Standpharm

Teva

Furazolidone Segment by Type

Pharma Grade

Industrial Grade

Others

Furazolidone Segment by Application

Pharmacy

Industry

Furazolidone Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Furazolidone market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Furazolidone and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Furazolidone.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Furazolidone market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2021-2032).

Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Furazolidone manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales of Furazolidone in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 7: Revenue of Furazolidone in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights of the report

More report detail

Tables and figures
List of Tables Table 1. Furazolidone Industry Trends Table 2. Furazolidone Industry Drivers Table 3. Furazolidone Industry Opportunities and Challenges Table 4. Furazolidone Industry Restraints Table 5. Global Furazolidone Revenue by Manufacturers (US$ Million) & (2021-2026) Table 6. Global Furazolidone Revenue Market Share by Manufacturers (2021-2026) Table 7. Global Furazolidone Sales by Manufacturers (K Units) & (2021-2026) Table 8. Global Furazolidone Sales Market Share by Manufacturers Table 9. Global Furazolidone Average Sales Price (US$/Unit) of Manufacturers (2021-2026) Table 10. Global Furazolidone Industry Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 11. Global Furazolidone Key Manufacturers Manufacturing Sites & Headquarters Table 12. Global Furazolidone Manufacturers, Product Type & Application Table 13. Global Furazolidone Manufacturers Establishment Date Table 14. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 15. Global Furazolidone by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2025) Table 16. Major Manufacturers of Pharma Grade Table 17. Major Manufacturers of Industrial Grade Table 18. Major Manufacturers of Others Table 19. Global Furazolidone Sales by Type 2021 VS 2025 VS 2032 (K Units) Table 20. Global Furazolidone Sales by Type (2021-2026) & (K Units) Table 21. Global Furazolidone Sales by Type (2027-2032) & (K Units) Table 22. Global Furazolidone Sales Market Share by Type (2021-2026) Table 23. Global Furazolidone Sales Market Share by Type (2027-2032) Table 24. Global Furazolidone Revenue by Type 2021 VS 2025 VS 2032 (K Units) Table 25. Global Furazolidone Revenue by Type (2021-2026) & (K Units) Table 26. Global Furazolidone Revenue by Type (2027-2032) & (K Units) Table 27. Global Furazolidone Revenue Market Share by Type (2021-2026) Table 28. Global Furazolidone Revenue Market Share by Type (2027-2032) Table 29. Major Manufacturers of Pharmacy Table 30. Major Manufacturers of Industry Table 31. Global Furazolidone Sales by Application 2021 VS 2025 VS 2032 (K Units) Table 32. Global Furazolidone Sales by Application (2021-2026) & (K Units) Table 33. Global Furazolidone Sales by Application (2027-2032) & (K Units) Table 34. Global Furazolidone Sales Market Share by Application (2021-2026) Table 35. Global Furazolidone Sales Market Share by Application (2027-2032) Table 36. Global Furazolidone Revenue by Application 2021 VS 2025 VS 2032 (K Units) Table 37. Global Furazolidone Revenue by Application (2021-2026) & (K Units) Table 38. Global Furazolidone Revenue by Application (2027-2032) & (K Units) Table 39. Global Furazolidone Revenue Market Share by Application (2021-2026) Table 40. Global Furazolidone Revenue Market Share by Application (2027-2032) Table 41. Global Furazolidone Sales by Region: 2021 VS 2025 VS 2032 (K Units) Table 42. Global Furazolidone Sales by Region (2021-2026) & (K Units) Table 43. Global Furazolidone Sales Market Share by Region (2021-2026) Table 44. Global Furazolidone Sales Forecasted by Region (2027-2032) & (K Units) Table 45. Global Furazolidone Sales Forecasted Market Share by Region (2027-2032) Table 46. North America Furazolidone Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 47. North America Furazolidone Sales by Country (2021-2026) & (K Units) Table 48. North America Furazolidone Sales by Country (2027-2032) & (K Units) Table 49. Europe Furazolidone Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 50. Europe Furazolidone Sales by Country (2021-2026) & (K Units) Table 51. Europe Furazolidone Sales by Country (2027-2032) & (K Units) Table 52. Asia Pacific Furazolidone Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 53. Asia Pacific Furazolidone Sales by Country (2021-2026) & (K Units) Table 54. Asia Pacific Furazolidone Sales by Country (2027-2032) & (K Units) Table 55. South America, Middle East and Africa Furazolidone Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 56. South America, Middle East and Africa Furazolidone Sales by Country (2021-2026) & (K Units) Table 57. South America, Middle East and Africa Furazolidone Sales by Country (2027-2032) & (K Units) Table 58. Global Furazolidone Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 59. Global Furazolidone Revenue by Region (2021-2026) & (US$ Million) Table 60. Global Furazolidone Revenue by Region (2027-2032) & (US$ Million) Table 61. Global Furazolidone Revenue Market Share by Region (2021-2026) Table 62. Global Furazolidone Revenue Market Share by Region (2027-2032) Table 63. Becton, Dickinson and Company (BD) Company Information Table 64. Becton, Dickinson and Company (BD) Business Overview Table 65. Becton, Dickinson and Company (BD) Furazolidone Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 66. Becton, Dickinson and Company (BD) Furazolidone Product Portfolio Table 67. Becton, Dickinson and Company (BD) Recent Development Table 68. Daiichi Sankyo Company Information Table 69. Daiichi Sankyo Business Overview Table 70. Daiichi Sankyo Furazolidone Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 71. Daiichi Sankyo Furazolidone Product Portfolio Table 72. Daiichi Sankyo Recent Development Table 73. Ferring Company Information Table 74. Ferring Business Overview Table 75. Ferring Furazolidone Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 76. Ferring Furazolidone Product Portfolio Table 77. Ferring Recent Development Table 78. Geo-Med Company Information Table 79. Geo-Med Business Overview Table 80. Geo-Med Furazolidone Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 81. Geo-Med Furazolidone Product Portfolio Table 82. Geo-Med Recent Development Table 83. GrÜNenthal Gmbh Company Information Table 84. GrÜNenthal Gmbh Business Overview Table 85. GrÜNenthal Gmbh Furazolidone Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 86. GrÜNenthal Gmbh Furazolidone Product Portfolio Table 87. GrÜNenthal Gmbh Recent Development Table 88. Keyfarm Company Information Table 89. Keyfarm Business Overview Table 90. Keyfarm Furazolidone Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 91. Keyfarm Furazolidone Product Portfolio Table 92. Keyfarm Recent Development Table 93. KPL Pharma Company Information Table 94. KPL Pharma Business Overview Table 95. KPL Pharma Furazolidone Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 96. KPL Pharma Furazolidone Product Portfolio Table 97. KPL Pharma Recent Development Table 98. Marvi Company Information Table 99. Marvi Business Overview Table 100. Marvi Furazolidone Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 101. Marvi Furazolidone Product Portfolio Table 102. Marvi Recent Development Table 103. Standpharm Company Information Table 104. Standpharm Business Overview Table 105. Standpharm Furazolidone Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 106. Standpharm Furazolidone Product Portfolio Table 107. Standpharm Recent Development Table 108. Teva Company Information Table 109. Teva Business Overview Table 110. Teva Furazolidone Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 111. Teva Furazolidone Product Portfolio Table 112. Teva Recent Development Table 113. Key Raw Materials Table 114. Raw Materials Key Suppliers Table 115. Furazolidone Distributors List Table 116. Furazolidone Customers List Table 117. Research Programs/Design for This Report Table 118. Authors List of This Report Table 119. Secondary Sources Table 120. Primary Sources List of Figures Figure 1. Furazolidone Product Image Figure 2. Global Furazolidone Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Furazolidone Market Size (2021-2032) & (US$ Million) Figure 4. Global Furazolidone Sales (2021-2032) & (K Units) Figure 5. Global Furazolidone Average Price (US$/Unit) & (2021-2032) Figure 6. Global Top 5 and 10 Furazolidone Players Market Share by Revenue in 2025 Figure 7. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 8. Pharma Grade Image Figure 9. Industrial Grade Image Figure 10. Others Image Figure 11. Global Furazolidone Sales by Type (2021 VS 2025 VS 2032) & (K Units) Figure 12. Global Furazolidone Sales Market Share 2021 VS 2025 VS 2032 Figure 13. Global Furazolidone Sales Market Share by Type (2021-2032) Figure 14. Global Furazolidone Revenue by Type (2021 VS 2025 VS 2032) & (K Units) Figure 15. Global Furazolidone Revenue Market Share 2021 VS 2025 VS 2032 Figure 16. Global Furazolidone Revenue Market Share by Type (2021-2032) Figure 17. Pharmacy Image Figure 18. Industry Image Figure 19. Global Furazolidone Sales by Application (2021 VS 2025 VS 2032) & (K Units) Figure 20. Global Furazolidone Sales Market Share 2021 VS 2025 VS 2032 Figure 21. Global Furazolidone Sales Market Share by Application (2021-2032) Figure 22. Global Furazolidone Revenue by Application (2021 VS 2025 VS 2032) & (K Units) Figure 23. Global Furazolidone Revenue Market Share 2021 VS 2025 VS 2032 Figure 24. Global Furazolidone Revenue Market Share by Application (2021-2032) Figure 25. North America Furazolidone Sales and Growth Rate (2021-2032) & (K Units) Figure 26. North America Furazolidone Sales Market Share by Country (2021-2032) Figure 27. U.S. Furazolidone Sales and Growth Rate (2021-2032) & (K Units) Figure 28. Canada Furazolidone Sales and Growth Rate (2021-2032) & (K Units) Figure 29. Mexico Furazolidone Sales and Growth Rate (2021-2032) & (K Units) Figure 30. Europe Furazolidone Sales and Growth Rate (2021-2032) & (K Units) Figure 31. Europe Furazolidone Sales Market Share by Country (2021-2032) Figure 32. Germany Furazolidone Sales and Growth Rate (2021-2032) & (K Units) Figure 33. France Furazolidone Sales and Growth Rate (2021-2032) & (K Units) Figure 34. U.K. Furazolidone Sales and Growth Rate (2021-2032) & (K Units) Figure 35. Italy Furazolidone Sales and Growth Rate (2021-2032) & (K Units) Figure 36. Netherlands Furazolidone Sales and Growth Rate (2021-2032) & (K Units) Figure 37. Asia Pacific Furazolidone Sales and Growth Rate (2021-2032) & (K Units) Figure 38. Asia Pacific Furazolidone Sales Market Share by Country (2021-2032) Figure 39. China Furazolidone Sales and Growth Rate (2021-2032) & (K Units) Figure 40. Japan Furazolidone Sales and Growth Rate (2021-2032) & (K Units) Figure 41. South Korea Furazolidone Sales and Growth Rate (2021-2032) & (K Units) Figure 42. Southeast Asia Furazolidone Sales and Growth Rate (2021-2032) & (K Units) Figure 43. India Furazolidone Sales and Growth Rate (2021-2032) & (K Units) Figure 44. Australia Furazolidone Sales and Growth Rate (2021-2032) & (K Units) Figure 45. South America, Middle East and Africa Furazolidone Sales and Growth Rate (2021-2032) & (K Units) Figure 46. South America, Middle East and Africa Furazolidone Sales Market Share by Country (2021-2032) Figure 47. Brazil Furazolidone Sales and Growth Rate (2021-2032) & (K Units) Figure 48. South Africa Furazolidone Sales and Growth Rate (2021-2032) & (K Units) Figure 49. Saudi Arabia Furazolidone Sales and Growth Rate (2021-2032) & (K Units) Figure 50. Turkey Furazolidone Sales and Growth Rate (2021-2032) & (K Units) Figure 51. Argentina Furazolidone Sales and Growth Rate (2021-2032) & (K Units) Figure 52. UAE Furazolidone Sales and Growth Rate (2021-2032) & (K Units) Figure 53. Egypt Furazolidone Sales and Growth Rate (2021-2032) & (K Units) Figure 54. Chile Furazolidone Sales and Growth Rate (2021-2032) & (K Units) Figure 55. Global Furazolidone Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 56. Global Furazolidone Revenue Market Share by Region in Percentage: 2025 Versus 2032 Figure 57. North America Furazolidone Revenue (2021-2032) & (US$ Million) Figure 58. North America Furazolidone Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 59. Europe Furazolidone Revenue (2021-2032) & (US$ Million) Figure 60. Europe Furazolidone Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 61. Asia-Pacific Furazolidone Revenue (2021-2032) & (US$ Million) Figure 62. Asia-Pacific Furazolidone Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 63. South America, Middle East and Africa Furazolidone Revenue (2021-2032) & (US$ Million) Figure 64. South America, Middle East and Africa Furazolidone Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 65. Furazolidone Value Chain Figure 66. Manufacturing Cost Structure Figure 67. Furazolidone Production Mode & Process Figure 68. Direct Comparison with Distribution Share Figure 69. Distributors Profiles Figure 70. Years Considered Figure 71. Research Process Figure 72. Key Executives Interviewed

Scope & coverage.

Types
  • Pharma Grade
  • Industrial Grade
  • Others
Applications
  • Pharmacy
  • Industry
Companies covered
  • Becton, Dickinson and Company (BD)
  • Daiichi Sankyo
  • Ferring
  • Geo-Med
  • GrÜNenthal Gmbh
  • Keyfarm
  • KPL Pharma
  • Marvi
  • Standpharm
  • Teva

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Furazolidone Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Furazolidone Market Size Estimates and Forecasts (2021-2032)
  4. 1.4 Global Furazolidone Sales Estimates and Forecasts (2021-2032)
  5. 1.5 Global Furazolidone Market Average Price (2021-2032)
  6. 1.6 Assumptions and Limitations
  7. 1.7 Study Goals and Objectives
2 Global Furazolidone Market Dynamics
  1. 2.1 Furazolidone Industry Trends
  2. 2.2 Furazolidone Industry Drivers
  3. 2.3 Furazolidone Industry Opportunities and Challenges
  4. 2.4 Furazolidone Industry Restraints
3 Furazolidone Market by Manufacturers
  1. 3.1 Global Furazolidone Revenue by Manufacturers (2021-2026)
  2. 3.2 Global Furazolidone Sales by Manufacturers (2021-2026)
  3. 3.3 Global Furazolidone Average Sales Price by Manufacturers (2021-2026)
  4. 3.4 Global Furazolidone Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Furazolidone Key Manufacturers Manufacturing Sites & Headquarters
  6. 3.6 Global Furazolidone Manufacturers, Product Type & Application
  7. 3.7 Global Furazolidone Manufacturers Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Furazolidone Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Furazolidone Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Furazolidone Tier 1, Tier 2, and Tier 3
4 Furazolidone Market by Type
  1. 4.1 Furazolidone Type Introduction
  2. 4.1.1 Pharma Grade
  3. 4.1.2 Industrial Grade
  4. 4.1.3 Others
  5. 4.2 Global Furazolidone Sales by Type
  6. 4.2.1 Global Furazolidone Sales by Type (2021 VS 2025 VS 2032)
  7. 4.2.2 Global Furazolidone Sales by Type (2021-2032)
  8. 4.2.3 Global Furazolidone Sales Market Share by Type (2021-2032)
  9. 4.3 Global Furazolidone Revenue by Type
  10. 4.3.1 Global Furazolidone Revenue by Type (2021 VS 2025 VS 2032)
  11. 4.3.2 Global Furazolidone Revenue by Type (2021-2032)
  12. 4.3.3 Global Furazolidone Revenue Market Share by Type (2021-2032)
5 Furazolidone Market by Application
  1. 5.1 Furazolidone Application Introduction
  2. 5.1.1 Pharmacy
  3. 5.1.2 Industry
  4. 5.2 Global Furazolidone Sales by Application
  5. 5.2.1 Global Furazolidone Sales by Application (2021 VS 2025 VS 2032)
  6. 5.2.2 Global Furazolidone Sales by Application (2021-2032)
  7. 5.2.3 Global Furazolidone Sales Market Share by Application (2021-2032)
  8. 5.3 Global Furazolidone Revenue by Application
  9. 5.3.1 Global Furazolidone Revenue by Application (2021 VS 2025 VS 2032)
  10. 5.3.2 Global Furazolidone Revenue by Application (2021-2032)
  11. 5.3.3 Global Furazolidone Revenue Market Share by Application (2021-2032)
6 Global Furazolidone Sales by Region
  1. 6.1 Global Furazolidone Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Furazolidone Sales by Region (2021-2032)
  3. 6.2.1 Global Furazolidone Sales by Region (2021-2026)
  4. 6.2.2 Global Furazolidone Sales Forecasted by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Furazolidone Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  7. 6.3.2 North America Furazolidone Sales by Country (2021-2032)
  8. 6.3.3 U.S.
  9. 6.3.4 Canada
  10. 6.3.5 Mexico
  11. 6.4 Europe
  12. 6.4.1 Europe Furazolidone Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  13. 6.4.2 Europe Furazolidone Sales by Country (2021-2032)
  14. 6.4.3 Germany
  15. 6.4.4 France
  16. 6.4.5 U.K.
  17. 6.4.6 Italy
  18. 6.4.7 Netherlands
  19. 6.5 Asia Pacific
  20. 6.5.1 Asia Pacific Furazolidone Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  21. 6.5.2 Asia Pacific Furazolidone Sales by Country (2021-2032)
  22. 6.5.3 China
  23. 6.5.4 Japan
  24. 6.5.5 South Korea
  25. 6.5.6 Southeast Asia
  26. 6.5.7 India
  27. 6.5.8 Australia
  28. 6.6 South America, Middle East and Africa
  29. 6.6.1 South America, Middle East and Africa Furazolidone Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  30. 6.6.2 South America, Middle East and Africa Furazolidone Sales by Country (2021-2032)
  31. 6.6.3 Brazil
  32. 6.6.4 South Africa
  33. 6.6.5 Saudi Arabia
  34. 6.6.6 Turkey
  35. 6.6.6 Argentina
  36. 6.6.6 UAE
  37. 6.6.6 Egypt
  38. 6.6.6 Chile
7 Global Furazolidone Revenue by Region
  1. 7.1 Global Furazolidone Revenue by Region
  2. 7.1.1 Global Furazolidone Revenue by Region: 2021 VS 2025 VS 2032
  3. 7.1.2 Global Furazolidone Revenue by Region (2021-2026)
  4. 7.1.3 Global Furazolidone Revenue by Region (2027-2032)
  5. 7.1.4 Global Furazolidone Revenue Market Share by Region (2021-2032)
  6. 7.2 North America
  7. 7.2.1 North America Furazolidone Revenue (2021-2032)
  8. 7.2.2 North America Furazolidone Revenue Share by Country: 2021 VS 2025 VS 2032
  9. 7.3 Europe
  10. 7.3.1 Europe Furazolidone Revenue (2021-2032)
  11. 7.3.2 Europe Furazolidone Revenue Share by Country: 2021 VS 2025 VS 2032
  12. 7.4 Asia-Pacific
  13. 7.4.1 Asia-Pacific Furazolidone Revenue (2021-2032)
  14. 7.4.2 Asia-Pacific Furazolidone Revenue Share by Country: 2021 VS 2025 VS 2032
  15. 7.5 South America, Middle East and Africa
  16. 7.5.1 South America, Middle East and Africa Furazolidone Revenue (2021-2032)
  17. 7.5.2 South America, Middle East and Africa Furazolidone Revenue Share by Country: 2021 VS 2025 VS 2032
8 Company Profiles
  1. 8.1 Becton, Dickinson and Company (BD)
  2. 8.1.1 Becton, Dickinson and Company (BD) Company Information
  3. 8.1.2 Becton, Dickinson and Company (BD) Business Overview
  4. 8.1.3 Becton, Dickinson and Company (BD) Furazolidone Sales, Price, Revenue and Gross Margin (2021-2026)
  5. 8.1.4 Becton, Dickinson and Company (BD) Furazolidone Product Portfolio
  6. 8.1.5 Becton, Dickinson and Company (BD) Recent Developments
  7. 8.2 Daiichi Sankyo
  8. 8.2.1 Daiichi Sankyo Company Information
  9. 8.2.2 Daiichi Sankyo Business Overview
  10. 8.2.3 Daiichi Sankyo Furazolidone Sales, Price, Revenue and Gross Margin (2021-2026)
  11. 8.2.4 Daiichi Sankyo Furazolidone Product Portfolio
  12. 8.2.5 Daiichi Sankyo Recent Developments
  13. 8.3 Ferring
  14. 8.3.1 Ferring Company Information
  15. 8.3.2 Ferring Business Overview
  16. 8.3.3 Ferring Furazolidone Sales, Price, Revenue and Gross Margin (2021-2026)
  17. 8.3.4 Ferring Furazolidone Product Portfolio
  18. 8.3.5 Ferring Recent Developments
  19. 8.4 Geo-Med
  20. 8.4.1 Geo-Med Company Information
  21. 8.4.2 Geo-Med Business Overview
  22. 8.4.3 Geo-Med Furazolidone Sales, Price, Revenue and Gross Margin (2021-2026)
  23. 8.4.4 Geo-Med Furazolidone Product Portfolio
  24. 8.4.5 Geo-Med Recent Developments
  25. 8.5 GrÜNenthal Gmbh
  26. 8.5.1 GrÜNenthal Gmbh Company Information
  27. 8.5.2 GrÜNenthal Gmbh Business Overview
  28. 8.5.3 GrÜNenthal Gmbh Furazolidone Sales, Price, Revenue and Gross Margin (2021-2026)
  29. 8.5.4 GrÜNenthal Gmbh Furazolidone Product Portfolio
  30. 8.5.5 GrÜNenthal Gmbh Recent Developments
  31. 8.6 Keyfarm
  32. 8.6.1 Keyfarm Company Information
  33. 8.6.2 Keyfarm Business Overview
  34. 8.6.3 Keyfarm Furazolidone Sales, Price, Revenue and Gross Margin (2021-2026)
  35. 8.6.4 Keyfarm Furazolidone Product Portfolio
  36. 8.6.5 Keyfarm Recent Developments
  37. 8.7 KPL Pharma
  38. 8.7.1 KPL Pharma Company Information
  39. 8.7.2 KPL Pharma Business Overview
  40. 8.7.3 KPL Pharma Furazolidone Sales, Price, Revenue and Gross Margin (2021-2026)
  41. 8.7.4 KPL Pharma Furazolidone Product Portfolio
  42. 8.7.5 KPL Pharma Recent Developments
  43. 8.8 Marvi
  44. 8.8.1 Marvi Company Information
  45. 8.8.2 Marvi Business Overview
  46. 8.8.3 Marvi Furazolidone Sales, Price, Revenue and Gross Margin (2021-2026)
  47. 8.8.4 Marvi Furazolidone Product Portfolio
  48. 8.8.5 Marvi Recent Developments
  49. 8.9 Standpharm
  50. 8.9.1 Standpharm Company Information
  51. 8.9.2 Standpharm Business Overview
  52. 8.9.3 Standpharm Furazolidone Sales, Price, Revenue and Gross Margin (2021-2026)
  53. 8.9.4 Standpharm Furazolidone Product Portfolio
  54. 8.9.5 Standpharm Recent Developments
  55. 8.10 Teva
  56. 8.10.1 Teva Company Information
  57. 8.10.2 Teva Business Overview
  58. 8.10.3 Teva Furazolidone Sales, Price, Revenue and Gross Margin (2021-2026)
  59. 8.10.4 Teva Furazolidone Product Portfolio
  60. 8.10.5 Teva Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Furazolidone Value Chain Analysis
  2. 9.1.1 Furazolidone Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Furazolidone Production Mode & Process
  6. 9.2 Furazolidone Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Furazolidone Distributors
  9. 9.2.3 Furazolidone Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources
    8. 11.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research, Inc.
    Talk to an analyst